Head and Neck - Epstein Barr

Randomized Phase II And Phase III Studies Of Individualized Treatment For Nasopharyngeal Carcinoma Based On Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA) (NRG-HN001) 

Please contact Jamie Ford or Caroline Holcomb at (520) 626-6800 for further information regarding our clinical trials.

An Institutional Review Board responsible for human subjects research at The University of Arizona reviewed this research project and found it to be acceptable, according to applicable state and federal regulations and University policies designed to protect the rights and welfare of participants in research.